Global Marine Biotechnology
Market to Reach US$4.1 Billion by 2015
Marine biotechnology plays a key role
in exploring and studying various marine biological resources.
Marine biotechnology comprises broad range of subjects such as
marine environmental protection, marine bioactive substances,
genetics, marineculture, fermentation engineering and enzyme
engineering.
However, marine biotechnology market
is still in a nascent stage and accounts for a tiny percentage of
the overall biotechnology
market. During the years 2008 and 2009, the global marine
biotechnology market witnessed a slowdown owing to the global
economic meltdown. Nonetheless, the market gained momentum in 2010
with the recovery of economic situation and is expected to post
substantial growth in ensuing years. Given the vast untapped
potential, the marine biotech sector holds promising growth
prospects for the future.
United States represents the single largest region for marine
biotechnology worldwide, as stated by the new market research
report on Marine
Biotechnology. The US is the world leader in marine science
research and is home to highly developed international marine
research centers specializing in marine biotechnology. Marine
Bioactive Substances market is forecast to register the fastest
growth rate of more than 4.0% during the period 2009-2015.
Marine
Biomaterials market is projected to reach US$1.7 billion by
2012. In terms of end-use, Healthcare/biotechnology constitutes the
largest as well as fastest growing end-use segment for marine
biotechnology.
Marine resources have a significant impact on social safety and
national economy. Biotechnology not only lends a big hand in
maximizing utilization of marine resources, but also conserves and
safeguards these resources. Despite this, marine biotechnology was
not a significant area of investment until recently. Very few
countries have initiated national R&D programs to exploit
benefits of biotechnology in the marine sector. However, research
activity has gained momentum fueled by new technologies that
address technical challenges. Underwater technology; chemical and
analytical methods; and remote sensing provide vital information on
marine resources hitherto unexplored. In addition, advances in
aquaculture, drug discovery and fisheries are expected to encourage
application of biotechnology in marine industry.
Major players profiled in the report include Aker BioMarine ASA,
CP Kelco US Inc., Cyanotech Corp., Elan Corporation plc, FMC Corp.,
FMC Biopolymers AS, GlycoMar Ltd., Integrin Advanced Biosystems,
International Specialty Products Inc., Lonza Group Ltd, MariCal,
Marinova, Martek Biosciences Corp., Mera Pharmaceuticals Inc, New
England Biolabs Inc, PharmaMar S.A, PML Applications Ltd., Primex
Ltd, Prolume Ltd, Sea Run Holdings Inc, and Tequesta Marine
Biosciences.
The research report titled “Marine Biotechnology: A Global
Strategic Business Report” announced by Global Industry Analysts
Inc., provides a comprehensive review of the marine biotechnology
markets, impact of recession on the markets, current market trends,
key growth drivers, recent product introductions, recent industry
activity, and profiles of major/niche global as well as regional
market participants. The report provides annual sales estimates and
projections for the years 2009 through 2015 for the following
geographic markets – US, and Rest of World. Key segments analyzed
include Marine Biomaterials, Marine Bioactive Substances and Others
(including Marine Biomass and Marine Bio-Process). The study also
analyzes the market by end-use segments, which include Industrial
Products, Healthcare/Biotechnology, Consumer Products, Public
Services and Infrastructure, and Others (includes Mining and
Agricultural Applications). Also, a six-year (2003-2008) historic
analysis is provided for additional perspective.
For more details about this comprehensive market research
report, please visit – this
site